These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5901985)

  • 1. Hydroxocobalamin. IV. Biological half-life of hydroxocobalamin in the human liver.
    Glass GB; Lee DH
    Blood; 1966 Feb; 27(2):227-33. PubMed ID: 5901985
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxocobalamin. VI. Comparison of intestinal absorption in man of large doses of hydroxocobalamin and cyanocobalamin.
    Weisberg H; Jerzy Glass GB
    Proc Soc Exp Biol Med; 1966 May; 122(1):25-8. PubMed ID: 5944880
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on intestinal absorption of hydroxocobalamin. II. Biological half life of hydroxocobalamin in small intestinal wall].
    Abe T; Nakajima T; Okamura H
    Nihon Ketsueki Gakkai Zasshi; 1966 Nov; 29(6):874-8. PubMed ID: 6009654
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic fate of 57Co-labeled hydroxocobalamin and 57Co-labeled 5,6-dimethylbenzimidazolylcobamide coenzyme in rats.
    Kinoshita K; Fujita T
    Chem Pharm Bull (Tokyo); 1973 Jun; 21(6):1291-4. PubMed ID: 4732294
    [No Abstract]   [Full Text] [Related]  

  • 5. Retention of cyanocobalamin, hydroxocobalamin, and coenzyme B12 after parenteral administration.
    Boddy K; King P; Mervyn L; Macleod A; Adams JF
    Lancet; 1968 Sep; 2(7570):710-2. PubMed ID: 4175091
    [No Abstract]   [Full Text] [Related]  

  • 6. Body retention of hydroxocobalamin and cyanocobalamin. BNL 6942.
    Schiffer LM; Price DC; Cohn SH; Cronkite EP
    Tech Rep Brookhaven Natl Lab; 1965; ():1-10. PubMed ID: 5295158
    [No Abstract]   [Full Text] [Related]  

  • 7. The nature of the radioactive material in urine after parenteral 57Co hydroxocobalamin.
    Kennedy EH; Adams JF
    Clin Sci; 1965 Dec; 29(3):417-25. PubMed ID: 5848697
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcobalamin II mediated delivery of albumin-bound hydroxocobalamin to human liver cells.
    Begley JA; Colligan PD; Chu RC
    Proc Soc Exp Biol Med; 1993 Nov; 204(2):206-10. PubMed ID: 8415778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient variation in pernicious anaemia, as shown in a clinical trial of cyanocobalamin, hydroxocobalamin and cyanocobalamin--zinc tannate.
    Tudhope GR; Swan HT; Spray GH
    Br J Haematol; 1967 Mar; 13(2):216-28. PubMed ID: 6019807
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintenance therapy of pernicious anaemia. Comparison of cyanocobalamin, hydroxocobalamin and a cyanocobalamin-zinc-tannate complex.
    Killander A; Werner I
    Acta Haematol; 1968; 40(6):305-14. PubMed ID: 4978697
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption of cyanocobalamin, coenzyme B 12 , methylcobalamin, and hydroxocobalamin at different dose levels.
    Adams JF; Ross SK; Mervyn L; Boddy K; King P
    Scand J Gastroenterol; 1971; 6(3):249-52. PubMed ID: 5560708
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue uptake and urinary excretion of radioactive cobamide analogues and inorganic cobalt in growing female rabbits.
    Rosenthal HL
    J Nutr; 1962 Nov; 78():348-52. PubMed ID: 13974978
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of cobalamin coenzymes by human cells in tissue culture.
    Mahoney MJ; Rosenberg LE
    J Lab Clin Med; 1971 Aug; 78(2):302-8. PubMed ID: 5567567
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of vitamin B12 metabolism in patients with chronic hepatitis and liver cirrhosis.
    Spârchez T; Gheorghescu B; Jovin G; Merculiev E
    Nucl Med (Stuttg); 1968 Dec; 7(4):371-87. PubMed ID: 5734063
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning.
    Houeto P; Hoffman JR; Imbert M; Levillain P; Baud FJ
    Lancet; 1995 Sep; 346(8975):605-8. PubMed ID: 7651005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of vertebragenous pain and sensitivity disorders using high doses of hydroxocobalamin].
    Hieber H
    Med Monatsschr; 1974 Dec; 28(12):545-8. PubMed ID: 4281049
    [No Abstract]   [Full Text] [Related]  

  • 17. [The Schilling test performed with Co58-hydroxocobalamin. Considerations on the kinetics of cyano- and hydroxocobalamin].
    Vaccari GL; Mucci P; Sternieri E; Morini A
    Boll Soc Ital Biol Sper; 1966 Jan; 42(2):47-50. PubMed ID: 5934093
    [No Abstract]   [Full Text] [Related]  

  • 18. Retention and distribution of B12 activity, and requirement for B12, following parenteral administration of hydroxocobalamin (Vibeden).
    Skouby AP
    Acta Med Scand; 1966 Jul; 180(1):95-105. PubMed ID: 5940732
    [No Abstract]   [Full Text] [Related]  

  • 19. CONVERSION OF CYANO- AND HYDROXO-COBALAMIN IN VIVO INTO CO-ENZYME FORM OF VITAMIN B12 IN THE RAT.
    UCHINO H; YAGIRI Y; YOSHINO T; KONDO M; WAKISAKA G
    Nature; 1965 Jan; 205():176-7. PubMed ID: 14276268
    [No Abstract]   [Full Text] [Related]  

  • 20. HYDROXOCOBALAMIN: EXCRETION AND RETENTION AFTER PARENTERAL DOSES IN ANEMIC AND NONANEMIC SUBJECTS, WITH REFERENCE TO THE TREATMENT OF VITAMIN B12 DEFICIENCY STATES.
    ADAMS JF; KENNEDY EH
    J Lab Clin Med; 1965 Mar; 65():450-8. PubMed ID: 14261326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.